SOAT1 and interstitial lung disease: Intriguingly, we also observed that JAK/STAT signaling, a molecular pathway known to be activated in interstitial lung diseases, was also significantly enriched in lung fibroblasts obtained from IPF patients (GSE135099, Figure 5A) and bleomycin-treated mice (GSE183657, Figure 5B).